Kangda Law Firm

Securities and Capital Markets

Partner

June 2012 – April 2013: Beijing Guofeng Law Firm, Lawyer Assistant, primarily engaged in corporate mergers and acquisitions and restructuring, IPO, refinancing of listed companies, fund investment, and standing corporate legal advisory services.

April 2013 – March 2014: A-share listed company, primarily responsible for legal affairs related to the capital markets department.

March 2014 – Present: Kangda Law Firm, Securities Department, Full-time Lawyer, primarily engaged in corporate mergers and acquisitions and restructuring, IPO, refinancing of listed companies, fund investment, and standing corporate legal advisory services.

Key Practice Areas: Corporate restructuring, listing and refinancing; acquisition and restructuring of listed companies; industrial consolidation and M&A; private equity financing; bond issuance; compliance and information disclosure of listed companies, and other capital market services. Clients span industries including high-end equipment manufacturing, new materials, fine chemicals, biomedicine, consumer goods, and telecommunications.

Experience:

Participated in the shareholding restructuring and initial public offerings (IPOs) of companies including Sinosteel Luoyang (688119), Huaxin New Materials (300717), Huami New Materials (836247) (Beijing Stock Exchange IPO), and Suobao Protein (603231).

Participated in the share issuance (refinancing) projects of companies including Dibo (600804), Modern Pharmaceutical (600420), Oriental Landscape (002310), Monalisa (002918), and Huaxiang Shares (603112).

Participated in investment, acquisition, and M&A projects including: Shouqi Zhixing's introduction of investment from Volkswagen; Shouqi Leasing's Series A, A+, and Series B financing; the establishment of a joint venture between Shandong Juming Machinery Co., Ltd. and Carraro International S.A.; the merger and acquisition of Huaxiang Shares; Shouqi Zhixing's absorption of its parent company Shouqi Zhiyuan; Shouqi Yueche's Series B and B+ financing; Keda Clean Energy's investment in Qinghai Fozhao Lithium Energy Development Co., Ltd. and Qinghai Weili New Energy Materials Co., Ltd.; Muyuan Co., Ltd.'s voting rights entrustment and tender offer exemption; Beyondsoft Corporation; China Cultural Industry Investment Fund; Deer Group Co., Ltd.; Deer Future; Beijing Keqiao Investment Advisory Co., Ltd.; Beijing Shengshijing Investment Management Co., Ltd.; CNNC Titanium Dioxide; Hongri Pharmaceutical; Monalisa; Zhonghuan Guotou Holdings Group Co., Ltd.; and Wu Zhenmian's acquisition of Yongyi Shares.

Chinese (Mandarin)

Master of Laws, University of International Business and Economics